Epigenica
PrivateLast Round
Grant
Sep 8, 2025
Total Funding Raised
$2.73M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Epigenica operates in Healthcare & Life Sciences and is based in Solna. Its latest recorded funding round was a Grant round in September 2025.
Epigenica is a biotechnology company that provides a high-throughput epigenetic screening platform for biomedical research, drug discovery, and diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epigenica Comparables
Compare Epigenica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PredictMe AB | 78% | |
| EpiCypher | 76% | |
| Arima Genomics | 66% |
For institutional investors. Book with your work email.
Epigenica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 8, 2025 | ||||
| Seed | Jun 30, 2025 | ||||
| Seed | Oct 16, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Epigenica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leksell Social Ventures | Seed |
| Navigare Ventures | Seed |
| Almi Invest AB | Seed |
| ScaleUp Life Science Invest | Seed |
| Voima Ventures | Seed |
| European Union | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 744% MoM, from 25 to 211.
- Mar 18, 2026
Partnered with PrimeTech to expand presence in Japan.
For institutional investors. Book with your work email.
Epigenica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Epigenica's valuation, stock price, and market status.
Is Epigenica a public or private company?
Epigenica is a private company.
What is the current stock price of Epigenica?
Epigenica is a private company, so its shares have no public market price. Caplight tracks Epigenica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Epigenica worth (valuation)?
Valuation information for Epigenica is not publicly available.
Can I buy Epigenica stock?
Epigenica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Epigenica's last funding round?
Epigenica's most recent funding round was Grant on September 8, 2025.
Who are the main investors in Epigenica?
Key investors in Epigenica include Voima Ventures.
Will Epigenica IPO soon?
No public IPO plans have been announced for Epigenica.
How can I track Epigenica secondary market activity?
Caplight tracks bids, offers, and trades in Epigenica's shares on secondary markets.